July 2018
Volume 59, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2018
Investigation of a rare risk variant in complement factor H for age-related macular degeneration in the Amish
Author Affiliations & Notes
  • Andrea R. Waksmunski
    Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio, United States
    Institute for Computational Biology, Case Western Reserve University, Cleveland, Ohio, United States
  • Kristy Miskimen
    Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, United States
  • Yeunjoo E. Song
    Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, United States
  • Renee Laux
    Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, United States
  • Denise Fuzzell
    Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, United States
  • Sarada Fuzzell
    Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, United States
  • Larry D. Adams
    Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States
  • Laura Caywood
    Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States
  • Michael Prough
    Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States
  • William K Scott
    Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States
  • Dwight Stambolian
    Ophthalmology and Genetics, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Margaret A Pericak-Vance
    Hussman Institute for Human Genomics, University of Miami, Miami, Florida, United States
  • Jonathan L Haines
    Institute for Computational Biology, Case Western Reserve University, Cleveland, Ohio, United States
    Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, United States
  • Footnotes
    Commercial Relationships   Andrea Waksmunski, None; Kristy Miskimen, None; Yeunjoo Song, None; Renee Laux, None; Denise Fuzzell, None; Sarada Fuzzell, None; Larry Adams, None; Laura Caywood, None; Michael Prough, None; William Scott, None; Dwight Stambolian, None; Margaret Pericak-Vance, None; Jonathan Haines, None
  • Footnotes
    Support  EY023164
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1420. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Andrea R. Waksmunski, Kristy Miskimen, Yeunjoo E. Song, Renee Laux, Denise Fuzzell, Sarada Fuzzell, Larry D. Adams, Laura Caywood, Michael Prough, William K Scott, Dwight Stambolian, Margaret A Pericak-Vance, Jonathan L Haines; Investigation of a rare risk variant in complement factor H for age-related macular degeneration in the Amish. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1420. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Genetic variants in complement factor H (CFH) are well-known risk factors for age-related macular degeneration (AMD). However, their functional consequences are not fully characterized. We previously identified a missense variant in CFH (rs570523689, CFH P503A) in 19 Amish individuals in Ohio and Indiana. The variant was strongly associated with AMD and computationally predicted to be damaging. In our work, we aimed to elucidate the functional effects of CFH P503A to offer insights into AMD risk and etiology in these carriers.

Methods : We used a customized TaqMan assay for CFH P503A to genotype about 1,300 Amish individuals from Ohio, Indiana, and Pennsylvania. A pedigree for the carriers was constructed using data from the Anabaptist Genealogy Database. To determine if CFH P503A has an effect on CFH transcription, we utilized splicing prediction software and measured CFH transcript levels in 40 blood samples from carriers and related non-carriers. We performed real-time quantitative PCR with 4 different TaqMan assays targeting the 3 protein-coding CFH transcripts and the large retained intron of CFH. P503A falls within the longest coding transcript and the large retained intron of CFH. We quantified expression relative to that observed for ARPE-19 cells in the same assays and compared the means among the sample groups using the Wilcoxon rank sum test and a significance threshold of p<0.05.

Results : We identified 33 additional CFH P503A carriers in the Ohio and Indiana Amish. The 52 carriers are interrelated through a 10-generation pedigree dating back to the 1700s. The variant is located near the end of an exon and is predicted to disrupt an exonic splicing enhancer site, which may alter splicing. The combined relative expression of the three protein-coding transcripts and the relative expression of the large retained intron of CFH were significantly higher in the carriers and non-carriers without AMD (n=14 for each group) compared to the AMD non-carriers (n=5).

Conclusions : We identified 52 CFH P503A carriers in the Ohio and Indiana Amish. We found that there were significant differences in relative CFH expression among some groups in our assays, but carrier status alone could not explain these differences. Functional studies into the effects of this variant on protein folding and binding are underway and may contribute to our knowledge of how this variant contributes to AMD risk.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×